| Serial Number | 97689880 |
| Word Mark | MMTS MULTI MINI TABLET SYSTEM |
| Filing Date | Wednesday, November 23, 2022 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, August 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 11, 2024 |
| Goods and Services | Manufacturing services to the specification of others in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems, including customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release systems; clinical manufacturing of drug compositions for others to support clinical trials; manufacturing process consulting services for others relating to technology scale-up and integration of technology into manufacturing processes |
| Goods and Services | Pharmaceutical and veterinary pharmaceutical preparations, in particular drug delivery compositions, drug carriers and drug delivery agents, capsules, sachets and sprinkles for pharmaceutical purposes, comprising multiparticulates or multiple units, used for the treatment of disorders or diseases in the gastrointestinal tract, in the digestive system, in the gut, in the immune systems, in the cardiovascular system, in the respiratory tract, in the blood, in the metabolism, in the nervous system, in the cognition, in the behavior, and in the reproductive tract, gastrointestinal infections, diarrhea, irritable bowel syndrome, inflammatory bowel syndrome disease, enterocolitis, enteritis, ulcerative colitis, cardiovascular disorders, hypertension, thrombosis, vasoconstriction, asthma, inflammation of respiratory tract, asthma, bronchoconstriction, thrombonemia, ipertriglyceremia, ipercholesterolemia, iperlipoproteinemia, blood anemia, hypocalcemia, diabetes, diabetic peripheral neuropathy, dyskinesia, hyperkinetic movements, enzyme deficiency, pancreatitis, pancreatectomy, steatorrhea, cystic fibrosis, Paget's disease, bacterial infections, viral infections, fungal infections, osteoporosis, cancer, mucosal and systemic inflammation, functional disease, abdominal pain, allergy, obesity, muscle spasticity, spasms, convulsion, dysthymia, schizophrenia, degenerative dementia, Alzheimer, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, attention deficit hyperactivity disorder, addiction, fibromyalgia, obsessive-compulsive disorders, pain, peripheral neuropathic pain, post-surgical pain, back-pain, osteoarthritis |
| NOT AVAILABLE | "MULTI MINI TABLET SYSTEM" |
| Goods and Services | Research and development services in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems; research and development services for the preparation of multiparticulates or multiple units dosage forms including capsules, sachets, sprinkles; research and development in the area of delivery systems with customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release; scientific research and development in the area of stability testing, physical characterization, in-vitro release testing |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 15, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 15, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 15, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ADARE PHARMACEUTICALS s.r.l. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Pessano con Bornago 20042 IT |
| Party Name | ADARE PHARMACEUTICALS s.r.l. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Pessano con Bornago 20042 IT |
| Event Date | Event Description |
| Saturday, November 26, 2022 | NEW APPLICATION ENTERED |
| Thursday, December 15, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 6, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, September 12, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 12, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 2, 2024 | ASSIGNED TO LIE |
| Thursday, May 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 6, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, May 6, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Monday, May 6, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, May 6, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, May 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 22, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 11, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 11, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 6, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |